Allianz Asset Management Gmb H Autolus Therapeutics PLC Transaction History

Allianz Asset Management Gmb H

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$5.39 - $7.29 $208,593 - $282,123	38,700 New	38,700 $246,000
Q3 2021 Nov 10, 2021	SELL	$5.32 - $7.37 $652,657 - $904,151	-122,680 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.78 - $7.96 $586,410 - $976,532	122,680 New	122,680 $815,000
Q4 2019 Feb 13, 2020	SELL	$11.13 - $16.28 $500,850 - $732,600	-45,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$9.79 - $16.72 $146,850 - $250,799	15,000 Added 50.0%	45,000 $553,000
Q2 2019 Aug 08, 2019	SELL	$15.1 - $31.25 $139,599 - $288,906	-9,245 Reduced 23.56%	30,000 $483,000
Q1 2019 May 13, 2019	SELL	$24.38 - $34.71 $161,273 - $229,606	-6,615 Reduced 14.42%	39,245 $1.24 Million
Q4 2018 Feb 14, 2019	SELL	$24.21 - $48.01 $493,884 - $979,404	-20,400 Reduced 30.79%	45,860 $1.48 Million
Q3 2018 Nov 13, 2018	BUY	$20.86 - $33.33 $1.38 Million - $2.21 Million	66,260 New	66,260 $2.03 Million

104

163M

2.8K

13.4K

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $272M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.